pharma news today glp-1 obesity drug What is the pipeline for future medications for obesity? 💊 Millions More Americans Gain

As medications like semaglutide and liraglutide continue reshaping obesity treatment, an important question emerges: Will these drugs eventually replace bariatric surgery

While INMDs product actually sucked and wouldnt even actually benefit at all from increased abdominoplasty rates, ESTAs product is quite good and we managed to get in before the market was fully aware

While this can be an intended effect, it's important not to reduce your intake of essential daily nutrients

Retrieved from Sweeting, A., Wong, J., Murphy, H

So your clinician may not be aware of these things, and it might be important for you to bring up because you're at risk